Anuh Pharma rises on receiving GMP certificate from COFEPRIS for two products

07 Dec 2015 Evaluate

Anuh Pharma is currently trading at Rs. 311.00, up by 7.30 points or 2.40% from its previous closing of Rs. 303.70 on the BSE.

The scrip opened at Rs. 304.00 and has touched a high and low of Rs. 330.00 and Rs. 304.00 respectively. So far 27,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 414.75 on 12-Aug-2015 and a 52 week low of Rs. 103.60 on 22-Dec-2014.

Last one week high and low of the scrip stood at Rs. 330.00 and Rs. 298.00 respectively. The current market cap of the company is Rs. 779.24 crore.

The promoters holding in the company stood at 70.77%, while Institutions and Non-Institutions held 0.08% and 29.15% respectively.

Anuh Pharma has received Good Manufacturing Practice (GMP) certificate from COFEPRIS (Health Authority of Mexico) for two products. These products are Chloramphenicol and Chloramphenicol Palmitate.

Anuh Pharma is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

Anuh Pharma Share Price

194.90 5.45 (2.88%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.